These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2607128)

  • 1. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    Cohn JB; Collins G; Ashbrook E; Wernicke JF
    Int Clin Psychopharmacol; 1989 Oct; 4(4):313-22. PubMed ID: 2607128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.
    Beasley CM; Holman SL; Potvin JH
    Ann Clin Psychiatry; 1993 Sep; 5(3):199-207. PubMed ID: 8281243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study of fluoxetine and imipramine in major depression.
    Bressa GM; Brugnoli R; Pancheri P
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():69-73. PubMed ID: 2783701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.
    Kane JM; Quitkin FM; Rifkin A; Ramos-Lorenzi JR; Nayak DD; Howard A
    Arch Gen Psychiatry; 1982 Sep; 39(9):1065-9. PubMed ID: 6810839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Amsterdam JD; Shults J
    Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative trial of a new antidepressant, fluoxetine.
    Levine S; Deo R; Mahadevan K
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():41-5. PubMed ID: 2644339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo response in depression: a search for predictors.
    Brown WA; Dornseif BE; Wernicke JF
    Psychiatry Res; 1988 Dec; 26(3):259-64. PubMed ID: 3065807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
    Heiligenstein JH; Tollefson GD; Faries DE
    Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.